HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 18-MAY-15 4ZVM TITLE OXIDIZED QUINONE REDUCTASE 2 IN COMPLEX WITH DOXORUBICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NRH DEHYDROGENASE [QUINONE] 2,NRH:QUINONE OXIDOREDUCTASE 2, COMPND 5 QUINONE REDUCTASE 2,QR2; COMPND 6 EC: 1.10.99.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NQO2, NMOR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEXHTA KEYWDS QUINONE REDUCTASE 2, DOXORUBICIN, OXIDOREDUCTASE-INHIBITOR COMPLEX, KEYWDS 2 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.K.LEUNG,B.H.SHILTON REVDAT 4 27-SEP-23 4ZVM 1 REMARK REVDAT 3 22-NOV-17 4ZVM 1 JRNL REMARK REVDAT 2 08-JUN-16 4ZVM 1 JRNL REVDAT 1 30-MAR-16 4ZVM 0 JRNL AUTH K.K.LEUNG,B.H.SHILTON JRNL TITL BINDING OF DNA-INTERCALATING AGENTS TO OXIDIZED AND REDUCED JRNL TITL 2 QUINONE REDUCTASE 2. JRNL REF BIOCHEMISTRY V. 54 7438 2015 JRNL REFN ISSN 0006-2960 JRNL PMID 26636353 JRNL DOI 10.1021/ACS.BIOCHEM.5B00884 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9-1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35798 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1765 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 15.5380 - 4.6018 1.00 2795 140 0.1380 0.1860 REMARK 3 2 4.6018 - 3.6684 1.00 2675 134 0.1301 0.1677 REMARK 3 3 3.6684 - 3.2093 1.00 2640 153 0.1534 0.2203 REMARK 3 4 3.2093 - 2.9180 1.00 2626 149 0.1676 0.2317 REMARK 3 5 2.9180 - 2.7100 1.00 2612 127 0.1750 0.2336 REMARK 3 6 2.7100 - 2.5510 1.00 2633 118 0.1741 0.2203 REMARK 3 7 2.5510 - 2.4237 1.00 2598 151 0.1771 0.2359 REMARK 3 8 2.4237 - 2.3186 1.00 2596 134 0.1773 0.2602 REMARK 3 9 2.3186 - 2.2296 0.99 2589 126 0.2693 0.3523 REMARK 3 10 2.2296 - 2.1529 1.00 2587 134 0.2180 0.3189 REMARK 3 11 2.1529 - 2.0857 1.00 2570 132 0.2030 0.2692 REMARK 3 12 2.0857 - 2.0262 1.00 2611 139 0.2036 0.2895 REMARK 3 13 2.0262 - 1.9730 0.98 2501 128 0.2218 0.2970 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.860 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3967 REMARK 3 ANGLE : 1.370 5424 REMARK 3 CHIRALITY : 0.054 574 REMARK 3 PLANARITY : 0.007 665 REMARK 3 DIHEDRAL : 14.019 1395 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZVM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209982. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC CONFOCOL MAX-FLUX (CMF) REMARK 200 GRAPHITE MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.1.0 REMARK 200 DATA SCALING SOFTWARE : SCALA 0.3.6 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35891 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 15.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.61400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 1QR2 REMARK 200 REMARK 200 REMARK: YELLOW RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7M AMMONIUM SULFATE, 0.1M HEPES PH REMARK 280 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.11500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.31000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.67000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.31000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.11500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.67000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ3 LYS A 157 O GLY A 229 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 547 O HOH B 560 4455 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 61 83.12 -175.12 REMARK 500 PRO A 62 0.15 -68.95 REMARK 500 TYR A 132 -130.40 47.43 REMARK 500 TYR A 155 53.19 -95.80 REMARK 500 ALA A 191 52.70 39.83 REMARK 500 ARG B 78 46.36 71.66 REMARK 500 TYR B 132 -123.11 39.71 REMARK 500 TYR B 155 52.53 -94.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 173 ND1 REMARK 620 2 HIS A 177 ND1 129.6 REMARK 620 3 CYS A 222 O 104.5 94.3 REMARK 620 4 CYS A 222 SG 121.3 104.1 91.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 173 ND1 REMARK 620 2 HIS B 177 ND1 108.7 REMARK 620 3 CYS B 222 O 107.9 98.4 REMARK 620 4 CYS B 222 SG 126.4 112.9 97.8 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAD A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DM2 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAD B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DM2 B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZVK RELATED DB: PDB REMARK 900 RELATED ID: 4ZVL RELATED DB: PDB REMARK 900 RELATED ID: 4ZVN RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE MISMATCH BETWEEN F46 (IN THE DEPOSITED STRUCTURE) AND L47 (FROM REMARK 999 UNP P16083) IS DUE TO SNP RS1143684. BOTH FORMS OF NQO2 ARE FOUND REMARK 999 IN THE POPULATION WHERE F46 IS THE PREDOMINANT FORM IN THE REMARK 999 POPULATION. FOR YOUR REFERENCE - 1. MEGARITY, C. F., GILL, J. R. E., REMARK 999 CARAHER, M. C., STRATFORD, I. J., NOLAN, K. A, AND TIMSON, D. J. REMARK 999 (2014) THE TWO COMMON POLYMORPHIC FORMS OF HUMAN NRH-QUINONE REMARK 999 OXIDOREDUCTASE 2 (NQO2) HAVE DIFFERENT BIOCHEMICAL PROPERTIES. FEBS REMARK 999 LETT. 588, 1666-72 DBREF 4ZVM A 1 230 UNP P16083 NQO2_HUMAN 2 231 DBREF 4ZVM B 1 230 UNP P16083 NQO2_HUMAN 2 231 SEQADV 4ZVM PHE A 46 UNP P16083 LEU 47 SEE REMARK 999 SEQADV 4ZVM PHE B 46 UNP P16083 LEU 47 SEE REMARK 999 SEQRES 1 A 230 ALA GLY LYS LYS VAL LEU ILE VAL TYR ALA HIS GLN GLU SEQRES 2 A 230 PRO LYS SER PHE ASN GLY SER LEU LYS ASN VAL ALA VAL SEQRES 3 A 230 ASP GLU LEU SER ARG GLN GLY CYS THR VAL THR VAL SER SEQRES 4 A 230 ASP LEU TYR ALA MET ASN PHE GLU PRO ARG ALA THR ASP SEQRES 5 A 230 LYS ASP ILE THR GLY THR LEU SER ASN PRO GLU VAL PHE SEQRES 6 A 230 ASN TYR GLY VAL GLU THR HIS GLU ALA TYR LYS GLN ARG SEQRES 7 A 230 SER LEU ALA SER ASP ILE THR ASP GLU GLN LYS LYS VAL SEQRES 8 A 230 ARG GLU ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU TYR SEQRES 9 A 230 TRP PHE SER VAL PRO ALA ILE LEU LYS GLY TRP MET ASP SEQRES 10 A 230 ARG VAL LEU CYS GLN GLY PHE ALA PHE ASP ILE PRO GLY SEQRES 11 A 230 PHE TYR ASP SER GLY LEU LEU GLN GLY LYS LEU ALA LEU SEQRES 12 A 230 LEU SER VAL THR THR GLY GLY THR ALA GLU MET TYR THR SEQRES 13 A 230 LYS THR GLY VAL ASN GLY ASP SER ARG TYR PHE LEU TRP SEQRES 14 A 230 PRO LEU GLN HIS GLY THR LEU HIS PHE CYS GLY PHE LYS SEQRES 15 A 230 VAL LEU ALA PRO GLN ILE SER PHE ALA PRO GLU ILE ALA SEQRES 16 A 230 SER GLU GLU GLU ARG LYS GLY MET VAL ALA ALA TRP SER SEQRES 17 A 230 GLN ARG LEU GLN THR ILE TRP LYS GLU GLU PRO ILE PRO SEQRES 18 A 230 CYS THR ALA HIS TRP HIS PHE GLY GLN SEQRES 1 B 230 ALA GLY LYS LYS VAL LEU ILE VAL TYR ALA HIS GLN GLU SEQRES 2 B 230 PRO LYS SER PHE ASN GLY SER LEU LYS ASN VAL ALA VAL SEQRES 3 B 230 ASP GLU LEU SER ARG GLN GLY CYS THR VAL THR VAL SER SEQRES 4 B 230 ASP LEU TYR ALA MET ASN PHE GLU PRO ARG ALA THR ASP SEQRES 5 B 230 LYS ASP ILE THR GLY THR LEU SER ASN PRO GLU VAL PHE SEQRES 6 B 230 ASN TYR GLY VAL GLU THR HIS GLU ALA TYR LYS GLN ARG SEQRES 7 B 230 SER LEU ALA SER ASP ILE THR ASP GLU GLN LYS LYS VAL SEQRES 8 B 230 ARG GLU ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU TYR SEQRES 9 B 230 TRP PHE SER VAL PRO ALA ILE LEU LYS GLY TRP MET ASP SEQRES 10 B 230 ARG VAL LEU CYS GLN GLY PHE ALA PHE ASP ILE PRO GLY SEQRES 11 B 230 PHE TYR ASP SER GLY LEU LEU GLN GLY LYS LEU ALA LEU SEQRES 12 B 230 LEU SER VAL THR THR GLY GLY THR ALA GLU MET TYR THR SEQRES 13 B 230 LYS THR GLY VAL ASN GLY ASP SER ARG TYR PHE LEU TRP SEQRES 14 B 230 PRO LEU GLN HIS GLY THR LEU HIS PHE CYS GLY PHE LYS SEQRES 15 B 230 VAL LEU ALA PRO GLN ILE SER PHE ALA PRO GLU ILE ALA SEQRES 16 B 230 SER GLU GLU GLU ARG LYS GLY MET VAL ALA ALA TRP SER SEQRES 17 B 230 GLN ARG LEU GLN THR ILE TRP LYS GLU GLU PRO ILE PRO SEQRES 18 B 230 CYS THR ALA HIS TRP HIS PHE GLY GLN HET ZN A 301 1 HET FAD A 302 53 HET DM2 A 303 68 HET ZN B 301 1 HET FAD B 302 53 HET DM2 B 303 68 HETNAM ZN ZINC ION HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM DM2 DOXORUBICIN HETSYN DM2 ADRIAMYCIN FORMUL 3 ZN 2(ZN 2+) FORMUL 4 FAD 2(C27 H33 N9 O15 P2) FORMUL 5 DM2 2(C27 H29 N O11) FORMUL 9 HOH *341(H2 O) HELIX 1 AA1 SER A 16 GLN A 32 1 17 HELIX 2 AA2 THR A 51 ILE A 55 5 5 HELIX 3 AA3 ASN A 66 GLN A 77 1 12 HELIX 4 AA4 ALA A 81 ALA A 94 1 14 HELIX 5 AA5 PRO A 109 LEU A 120 1 12 HELIX 6 AA6 PHE A 131 GLY A 135 5 5 HELIX 7 AA7 ASP A 163 HIS A 173 1 11 HELIX 8 AA8 LEU A 176 GLY A 180 5 5 HELIX 9 AA9 ALA A 191 ALA A 195 5 5 HELIX 10 AB1 SER A 196 THR A 213 1 18 HELIX 11 AB2 ILE A 214 GLU A 217 5 4 HELIX 12 AB3 THR A 223 GLY A 229 1 7 HELIX 13 AB4 SER B 16 GLN B 32 1 17 HELIX 14 AB5 THR B 51 ILE B 55 5 5 HELIX 15 AB6 ASN B 66 ARG B 78 1 13 HELIX 16 AB7 ALA B 81 ALA B 94 1 14 HELIX 17 AB8 PRO B 109 LEU B 120 1 12 HELIX 18 AB9 PHE B 131 GLY B 135 5 5 HELIX 19 AC1 ASP B 163 HIS B 173 1 11 HELIX 20 AC2 LEU B 176 GLY B 180 5 5 HELIX 21 AC3 SER B 196 THR B 213 1 18 HELIX 22 AC4 ILE B 214 GLU B 217 5 4 HELIX 23 AC5 THR B 223 GLY B 229 1 7 SHEET 1 AA1 5 THR A 35 ASP A 40 0 SHEET 2 AA1 5 LYS A 4 TYR A 9 1 N VAL A 5 O THR A 35 SHEET 3 AA1 5 LEU A 96 PRO A 102 1 O ILE A 98 N VAL A 8 SHEET 4 AA1 5 LEU A 141 THR A 147 1 O SER A 145 N PHE A 99 SHEET 5 AA1 5 LYS A 182 VAL A 183 1 O LYS A 182 N ALA A 142 SHEET 1 AA2 5 THR A 35 ASP A 40 0 SHEET 2 AA2 5 LYS A 4 TYR A 9 1 N VAL A 5 O THR A 35 SHEET 3 AA2 5 LEU A 96 PRO A 102 1 O ILE A 98 N VAL A 8 SHEET 4 AA2 5 LEU A 141 THR A 147 1 O SER A 145 N PHE A 99 SHEET 5 AA2 5 GLN A 187 SER A 189 1 O SER A 189 N VAL A 146 SHEET 1 AA3 5 THR B 35 ASP B 40 0 SHEET 2 AA3 5 LYS B 4 TYR B 9 1 N TYR B 9 O SER B 39 SHEET 3 AA3 5 LEU B 96 PRO B 102 1 O ILE B 98 N LEU B 6 SHEET 4 AA3 5 LEU B 141 THR B 148 1 O SER B 145 N PHE B 99 SHEET 5 AA3 5 LYS B 182 VAL B 183 1 O LYS B 182 N ALA B 142 SHEET 1 AA4 5 THR B 35 ASP B 40 0 SHEET 2 AA4 5 LYS B 4 TYR B 9 1 N TYR B 9 O SER B 39 SHEET 3 AA4 5 LEU B 96 PRO B 102 1 O ILE B 98 N LEU B 6 SHEET 4 AA4 5 LEU B 141 THR B 148 1 O SER B 145 N PHE B 99 SHEET 5 AA4 5 GLN B 187 PHE B 190 1 O SER B 189 N VAL B 146 LINK ND1 HIS A 173 ZN ZN A 301 1555 1555 2.15 LINK ND1 HIS A 177 ZN ZN A 301 1555 1555 2.09 LINK O CYS A 222 ZN ZN A 301 1555 1555 2.25 LINK SG CYS A 222 ZN ZN A 301 1555 1555 2.22 LINK ND1 HIS B 173 ZN ZN B 301 1555 1555 2.04 LINK ND1 HIS B 177 ZN ZN B 301 1555 1555 2.14 LINK O CYS B 222 ZN ZN B 301 1555 1555 2.10 LINK SG CYS B 222 ZN ZN B 301 1555 1555 2.24 CISPEP 1 ILE A 128 PRO A 129 0 -3.77 CISPEP 2 ILE B 128 PRO B 129 0 -5.89 SITE 1 AC1 3 HIS A 173 HIS A 177 CYS A 222 SITE 1 AC2 27 HIS A 11 SER A 16 PHE A 17 ASN A 18 SITE 2 AC2 27 SER A 20 PRO A 102 LEU A 103 TYR A 104 SITE 3 AC2 27 TRP A 105 PHE A 106 THR A 147 THR A 148 SITE 4 AC2 27 GLY A 149 GLY A 150 TYR A 155 GLU A 193 SITE 5 AC2 27 ARG A 200 DM2 A 303 HOH A 404 HOH A 408 SITE 6 AC2 27 HOH A 416 HOH A 421 HOH A 423 HOH A 491 SITE 7 AC2 27 ASN B 66 ASP B 117 HOH B 420 SITE 1 AC3 16 GLU A 73 TRP A 105 GLY A 149 GLY A 150 SITE 2 AC3 16 MET A 154 ASN A 161 ILE A 194 FAD A 302 SITE 3 AC3 16 HOH A 498 HOH A 502 HOH A 506 HOH A 517 SITE 4 AC3 16 GLN B 122 PHE B 126 PHE B 178 HOH B 490 SITE 1 AC4 3 HIS B 173 HIS B 177 CYS B 222 SITE 1 AC5 27 ASP A 117 HIS B 11 LYS B 15 SER B 16 SITE 2 AC5 27 PHE B 17 ASN B 18 SER B 20 PRO B 102 SITE 3 AC5 27 LEU B 103 TYR B 104 TRP B 105 PHE B 106 SITE 4 AC5 27 THR B 147 THR B 148 GLY B 149 GLY B 150 SITE 5 AC5 27 TYR B 155 GLU B 193 ARG B 200 LYS B 201 SITE 6 AC5 27 DM2 B 303 HOH B 409 HOH B 436 HOH B 440 SITE 7 AC5 27 HOH B 443 HOH B 449 HOH B 472 SITE 1 AC6 12 VAL A 69 PHE A 126 PHE A 178 LYS A 216 SITE 2 AC6 12 TRP B 105 GLY B 149 GLY B 150 MET B 154 SITE 3 AC6 12 ASN B 161 GLU B 193 ILE B 194 FAD B 302 CRYST1 56.230 83.340 106.620 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017784 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011999 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009379 0.00000